Bath & Body Works/$BBWI
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Bath & Body Works
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 4% of sales from international markets in fiscal 2025. For fiscal 2025, 77% of sales stemmed from the brick-and-mortar network of more than 1,900 retail stores, similar to 2024 levels, as consumer shopping patterns remained normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like lip.
- Ticker
- $BBWI
- Sector
- Consumer Discretionary
- Primary listing
- NYSE
- Employees
- 34,903
- Headquarters
- Columbus, United States
- Website
- www.bbwinc.com
BBWI Metrics
BasicAdvanced
$4.6B
5.88
$3.85
1.37
$0.80
3.54%
Price and volume
Market cap
$4.6B
Beta
1.37
52-week high
$24.94
52-week low
$14.28
Average daily volume
6.8M
Dividend rate
$0.80
Financial strength
Current ratio
1.201
Quick ratio
0.555
Long term debt to equity
-4.077
Total debt to equity
-4.501
Dividend payout ratio (TTM)
20.74%
Interest coverage (TTM)
3.98%
Profitability
EBITDA (TTM)
1,316
Gross margin (TTM)
43.04%
Net profit margin (TTM)
10.83%
Operating margin (TTM)
14.84%
Effective tax rate (TTM)
19.57%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
13.42%
Return on equity (TTM)
-60.05%
Valuation
Price to earnings (TTM)
5.879
Price to revenue (TTM)
0.635
Price to book
-4.33
Price to tangible book (TTM)
-2.47
Price to free cash flow (TTM)
4.441
Free cash flow yield (TTM)
22.52%
Free cash flow per share (TTM)
5.091
Dividend yield (TTM)
3.54%
Forward dividend yield
3.54%
Growth
Revenue change (TTM)
-2.20%
Earnings per share change (TTM)
13.66%
3-year revenue growth (CAGR)
-1.08%
10-year revenue growth (CAGR)
-5.26%
3-year earnings per share growth (CAGR)
7.90%
10-year earnings per share growth (CAGR)
-0.64%
10-year dividend per share growth (CAGR)
-9.62%
What the Analysts think about BBWI
Analyst ratings (Buy, Hold, Sell) for Bath & Body Works stock.
Analyst projections of the future price of Bath & Body Works stock.
Bulls say / Bears say
Q2 results beat guidance, and management raised its 2026 adjusted EPS outlook to $2.60–$2.80 while forecasting about $650 million in free cash flow. That gives the turnaround more financial support, although sales are still expected to fall this year. (Bath & Body Works)
Direct sales grew 3% in Q2, the channel’s first increase since 2021, while Amazon sales more than tripled from Q1 and the brand launched in more than 600 Ulta stores. These new routes to customers could help reduce reliance on its own shops. (Retail Dive, Bath & Body Works)
International expansion offers another route to growth: international and other sales rose 24.9% in Q2, and the company opened its first store and online destination in Brazil in July. The sales category also includes domestic wholesale, so the increase is not solely from overseas demand. (SEC, Bath & Body Works)
Q2’s reported adjusted EPS of $0.62 included about $80 million in tariff refunds; without that benefit, adjusted EPS would have been $0.31. The refund makes the profit beat less indicative of underlying earnings strength. (Bath & Body Works)
The company had $3.6 billion of total debt at 1 August 2026. That sizeable obligation could limit flexibility if weak sales persist while it funds its multi-year turnaround. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 15 Oct 2026.
BBWI Financial Performance
Revenues and expenses
BBWI Earnings Performance
Company profitability
Upcoming events
No upcoming events
BBWI News
AllArticlesVideos
Funds containing BBWI
AllUSDEURGBP
Fund name | Fund size | $BBWI weighting |
|---|---|---|
SPDR MSCI USA Small Cap Value Weighted$USSC | $1.1B | 0.20% |
SPDR S&P 400 US Mid Cap$SPY4 | $6.4B | 0.13% |
SPDR S&P 400 US Mid Cap£SPX4 | $6.4B | 0.13% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | $3.2B | 0.10% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | $3.2B | 0.10% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.


